High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?
about
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies.Management of advanced adult soft tissue sarcoma.Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.Utility values for advanced soft tissue sarcoma health States from the general public in the United kingdomCost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and sweden.Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).
P2860
Q33379481-CD857AE7-D5A9-41B4-9C6C-37082DE044D0Q33395415-504A1E9E-7D26-42C8-8FE8-B52C3E11D9B6Q35220462-F3C94D9B-71AF-4577-B6E8-39E4C2E54FB4Q36611978-B966161B-16B5-46BB-938B-18814F95AF69Q36674228-E312F752-5D7B-4E00-A0CD-12629F316298Q36695919-84E63015-6245-4B02-91BB-5D4D677137A3Q36731032-17075C4B-B1A4-4EBB-852E-B00C54C7C718Q37330372-E875446B-1930-4385-9317-5374DFF32EF2Q41501364-31802174-B3B7-4261-8BBC-16F8EAB4E5C8Q45071656-2750A8BB-FFFA-4278-8B57-43F0E21E7AE2
P2860
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@ast
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@en
type
label
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@ast
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@en
prefLabel
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@ast
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@en
P2093
P356
P1433
P1476
High-dose ifosfamide plus adri ...... ssue sarcomas: is it feasible?
@en
P2093
A Goldhirsch
F De Braud
M G Zampino
P304
P356
10.1023/A:1008311901856
P577
1998-08-01T00:00:00Z